Every vet strives to prescribe responsibly. But when results takes days, evidence-based decisions get harder. Our new blog breaks down The Diagnostic Hurdles Vets are facing and How We Can Overcome Them Together 📖 Read the full article: [https://lnkd.in/dBQ3wmm2] #FluoretiQ #VeterinaryScience #VERI5Vet #Diagnostics #OneHealth #Stewardship
FluoretiQ Limited
Medical Equipment Manufacturing
Bristol, England 2,042 followers
Make the first Prescription, the right Prescription
About us
We develop diagnostics that are fast, accurate and can be used at the point of care: ensuring the first prescription, is always the right prescription. Our technologies answer 2 vital questions to ensure effective and sustainable use of antibiotics: Does the patient have an infection treatable with antibiotics? NANOPLEX® is an advanced latex agglutination test that can be used to rapidly identify and quantify the cause of infection in 5 minutes. What will be the most effective antibiotic treatment? SCFI™ is a phenotypic, real-time and growth-free antibiotic susceptibility test that determines the most effective antibiotic in 30 minutes.
- Website
-
http://www.fluoretiq.com
External link for FluoretiQ Limited
- Industry
- Medical Equipment Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Bristol, England
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Synthetic Chemistry, Microbiology, Antimicrobial Resistance, Antibiotic Stewardship, Diagnostics, and Rapid testing
Locations
-
Primary
Get directions
St. Philips Central, Albert Road
Bristol, England BS2 0XJ, GB
Employees at FluoretiQ Limited
Updates
-
A sobering reminder from the World Health Organization’s GLASS 2024 report antimicrobial resistance (AMR) is no longer a distant threat; it’s here, growing, and affecting everyday practice. 📊 Key findings: • 1 in 6 laboratory-confirmed bacterial infections worldwide are resistant to at least one common antibiotic. • For urinary tract infections, it’s 1 in 3. • Resistance increased in 40 % of monitored pathogen–antibiotic pairs between 2018 and 2023. • The highest rates are seen in countries with limited surveillance and fragile health systems. (Source: WHO GLASS 2024) At FluoretiQ Limited, we believe meaningful action starts with better diagnostics. Every faster, evidence-based decision whether made by a vet or clinician helps reduce unnecessary antibiotic use and protects the medicines that still work. 🧬 Because stewardship begins with clarity. #FluoretiQ #AMR #OneHealth #DiagnosticsInnovation #MinutesNotDays #AntimicrobialStewardship #VetInnovation #PublicHealth
A sobering report from World Health Organization on global status of AMR has just been released: - Approximately 1 in 6 laboratory confirmed bacterial infections worldwide are caused by bacteria resistant to antibiotics (for urinary tract infections 1 in 3!) - AMR has increased in 40% of the specific pathogen- antibiotic combinations monitored between 2018-2023 - The frequency of AMR is highest in countries with low surveillance coverage - AMR disproportionately affects countries with fragile health systems and lower income levels AMR is real, global and growing How many more reports we need to read before significant actions are taken? https://lnkd.in/etRGMtvu
-
-
Should we be concerned about antimicrobial resistance (AMR)? Short answer: Yes. Absolutely. 🧪 AMR means the antibiotics we rely on or people and pets might stop working. 🐾 And it’s not just a human health issue. AMR in animals affects all of us. 🎥 In our latest video, our founder breaks it down and shares why AMR is a growing threat we can’t ignore. 👉 Watch the full video now on YouTube:(https://lnkd.in/dCg9E4C6) ✅ Like it? Hit that share and subscribe button to join the mission. #FluoretiQ #AMR #AntibioticResistance #PetHealth #VetLife #OneHealth #ScienceMadeSimple #VERI5Vet
-
Thank you so much for the kind words and support! 🙏 We’re proud to be part of a community that values purposeful innovation and real-world impact. Exciting times ahead as we continue shaping the future of point-of-care testing! 🚀
🧬 What does it take to build the future of diagnostics — where speed, accuracy, and accessibility truly come together? That’s the question FluoretiQ Limited is answering brilliantly in their latest video: 🎥 Watch here: https://lnkd.in/e3FajbJU A few key takeaways that stood out to us: 🔬 Reimagining how diagnostics work The team is tackling one of healthcare’s biggest challenges, making high-quality diagnostics faster, more affordable, and available where they’re needed most. 📈 Building for scale from day one Instead of chasing short-term wins, they’re setting up systems, partnerships, and processes that can truly grow with demand. ✅ Execution focus & traction proof points There’s substance behind the vision: measurable metrics, early wins, and meaningful customer/user feedback. It’s not just talk; they’re delivering. We’re incredibly proud to see this kind of thinking coming from our incubator community. It’s a powerful reminder that innovation isn’t just about ideas, it’s about disciplined execution and clarity of purpose. Congrats Neciah Dorh and Josephine Dohr!
🚀 The Blueprint Sessions | Episode 2: Building the Future of Diagnostics with Josephine Dorh
https://www.youtube.com/
-
🔬 The Blueprint Sessions | Episode 2: “Building the Future of Diagnostics with Josephine Dorh” is live! In this episode, FluoretiQ Limited CEO Neciah Dorh speaks with CTO & Co-founder Josephine Dorh about the journey from concept to clinical impact and the science behind FluoretiQ’s next-generation diagnostic platform, Veri-5 Vet. From early lab testing to applying a One Health lens across human and veterinary care, Josephine shares how innovation, collaboration, and purpose drive FluoretiQ’s mission forward. 📺 Watch the full episode now → [https://lnkd.in/dZpePbX7] #FluoretiQ #BlueprintSessions #DiagnosticsInnovation #LeadershipInScience #MinutesNotDays #HealthcareTechnology #Veri5 #OneHealth #VetCommunity
-
-
Did you know that some lab results take longer than a pet’s recovery time? Every hour counts when your patient’s in pain. Today's bacterial culture takes at least 24 hours for a negative result and it could take between 2-7 days, if there is bacterial growth. That’s valuable time when patients and vets are waiting for clarity. How fast are your results right now? Share your experience 👇 #MinutesNotDays #VetLife #DiagnosticsInnovation #FluoretiQ #FasterCare
-
Rethinking Pet Diagnostics | Our TechSPARK Feature Antimicrobial resistance (AMR) isn’t just a threat to human health, it’s fast becoming one for pets too. Conventional testing is too slow and centralised, leaving companion animals at risk and vets without timely answers. We’re proud to be featured by TechSPARK in their Tech for Good Month! Our team shares why it’s time for a major shift in veterinary diagnostics and how our Veri-5® Vet platform empowers vets with rapid, accurate results in just 15 minutes. 🐾 AMR is rising in animals 🕒 Standard tests take 2+ days 💡 Veri-5® Vet delivers answers in minutes Let’s give vets faster, smarter ways to protect animal health and fight AMR. Read the full guest blog and join the conversation: 🔗 Read the blog: https://hubs.li/Q03LtV1b0 #TechForGood #AMR #HealthTech
-
-
🐾 Rethinking diagnostics in veterinary care Antimicrobial resistance (AMR) isn’t just a human challenge, it’s impacting our pets too. Conventional culture-based testing takes days, delaying treatment and often leading to unnecessary suffering. That’s why we developed Veri-5® Vet, delivering accurate results in just 15 minutes, empowering vets with faster, smarter tools to safeguard animal health and combat AMR. We’re proud to be featured in Tech for Good Month by techSPARK uk, highlighting how innovation can make a real difference for pets, people, and public health. 🔗 Read the full guest blog: https://hubs.li/Q03LtV1b0 #TechForGood #AMR #HealthTech #VeterinaryInnovation #Diagnostics
Culture Change: Why Conventional Testing is Failing Our Pets The AMR crisis isn’t just a human health issue. It’s a growing problem in veterinary care too. And our current testing methods? They're too slow, too centralised, and often too late. In this Tech for Good Month guest blog, the brilliant team at FluoretiQ Limited explain why our pets deserve better, and how their Veri-5® Vet platform is revolutionising diagnostics to give vets faster, smarter tools to protect animal health and tackle antimicrobial resistance. ⚠️ AMR in companion animals is on the rise 🕒 Traditional culture-based testing takes 2+ days 🐶 Delays mean unnecessary suffering for pets 💡 Veri-5® Vet delivers accurate results in 15 minutes It’s time to rethink the diagnostic status quo. 🐾 🔗 Read the full guest blog here: https://hubs.li/Q03LtV1b0 #TechForGood #AMR #HealthTech
-
-
Great day, great connections and shared optimism for the future of healthcare. Thanks Benjamin Storey and the wider Barclays Demo Day team for organising yesterday's event!
Founder of Barclays Demo Directory | Head of Investor Connectivity @ Barclays UK | Market maker
🌟 What a Barclays Demo Directory Demo day! 🌟 Yesterday, we welcomed around 140 attendees to Barclays Head Office for our latest #DemoDirectory Demo Day — and what an incredible afternoon it was! 🚀 24 pan-UK #founders took to the stage to showcase their innovations in #Healthcare and #Sustainability, each delivering powerful 5-minute demos that sparked real #investor interest. From cutting-edge biotech to planet-positive solutions, the energy and ambition in the room were truly inspiring. 💬 The event featured two parallel stages, giving investors the freedom to explore and engage with the founders most aligned to their interests and we saw some fantastic connections being made. Healthcare stage was hosted with Chris Wheatcroft (Ascension) and Sustainability stage hosted by Andrew Wordsworth (Sustainable Ventures) 🍸 We wrapped up with drinks, nibbles, and buzzing conversations — the kind that lead to real opportunities and lasting partnerships. A huge thank you to all the founders who demoed, including: CanSense , Thalamos , Biozen , Circadacare , @GilesAI, @microneedle solutions, FluoretiQ Limited , Enteral Access Technologies , Sanome , Amilis , Digostics , HealthKey , Watergate , Kavaken , Aeropowder , ADAPTAVATE , Uali , Origen Carbon, ALTERED CARBON LTD, Infiniti Recycling Ltd, H2CHP Limited, MYOM , BindEthics Ltd. 👏 And to the team behind the scenes — Sheila Pandya, Mark Walker, Holly Roberts, Patrick Byrne, Harry Baker, Nigel Jones, Hollie Greenaway, Jade Jamel, Lilly Chatwin and Trish McClay – thank you greatly for delivering such an fantastic event. 📲 If you missed it, check out the Demo Directory platform to discover the businesses and founders driving innovation: https://lnkd.in/ehWb9exP Let’s keep the momentum going. #DemoDirectory Barclays Eagle Labs #Innovation #Healthcare #Sustainability #InvestorConnectivity #StartupShowcase Stephen Brown Clare Moses Samuel Hobbs
-
-
-
-
-
+3
-
-
🚀 Introducing: The Blueprint Sessions At FluoretiQ Limited, we know that creating meaningful solutions is about more than just the tech it’s about the people behind it, the pain points we’re solving, and the purpose driving us forward. That’s why we’re launching The Blueprint Sessions , a new video series where our CEO Neciah Dorh sits down with the brilliant minds building the next generation of diagnostics. 🔍 We’ll be talking strategy, challenges, and real-world breakthroughs all in the mission to deliver faster, smarter, and more accessible point-of-care tests for bacterial infections. 📺 Watch the first episode now → [https://lnkd.in/dCg9E4C6] 👍 Like, 🔁 share, and 🔔 subscribe to our channel to stay up to date on the future of diagnostic innovation. #FluoretiQ #BlueprintSessions #DiagnosticInnovation #VERI5Vet #OneHealth #PointOfCareTesting #AntibioticStewardship #VeterinaryDiagnostics #AMR #HealthcareInnovation